PMA device
Superion Interspinous Spacer
Boston Scientific Neuromodulation · Prosthesis, Spinous Process Spacer/Plate (NQO, Class III) · First FDA decision May 20, 2015, newest Feb 21, 2017Degenerative disc disease and spinal stenosis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
2
Naming "Superion Interspinous"
MAUDE reports
246
Brand "Superion Interspinous", since 2015
PubMed studies
14
Mentioning "Superion Interspinous"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Superion Interspinous Spacer
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- SUPERION INTERSPINOUS SPACERPMA supplement
P140004-S007 · Decided Feb 21, 2017 · 39 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
- Superion® Interspinous SpacerPMA supplement
P140004-S004 · Decided Oct 11, 2016 · 78 days after receipt · Normal 180 Day Track
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
- SUPERION INTERSPINOUS SPACERPMA supplement
P140004-S002 · Decided Dec 15, 2015 · 176 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, spinous process spacer/plate (NQO) · Orthopedic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Superion Interspinous", any status and sponsor, newest update first.
Boston Scientific CorporationPublic (BSX)
NCT04087811 · 1,674 participants · Start Nov 28, 2016 · Primary completion Mar 1, 2021
Device: Superion® Indirect Decompression System (IDS) · For: Lumbar Spinal Stenosis
Sites: Birmingham, Alabama; Phoenix, Arizona; Scottsdale, Arizona · 66 sites in all
- Investigating Superion™ In Spinal StenosisPivotal-lookingCompleted
Boston Scientific CorporationPublic (BSX)
NCT00692276 · 391 participants · Start Jun 2008 · Primary completion Feb 2017
Device: Superion™ Interspinous Spacer; X-STOP® IPD® Device · For: Lumbar Spinal Stenosis; Intermittent Claudication
Sites: Phoenix, Arizona; Tucson, Arizona; Beverly Hills, California · 32 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Superion Interspinous", and for the whole product code for context.
This brand
246 reports: 19 malfunction, 226 injury, 1 death
Whole product code NQO
2,342 reports: 1,410 malfunction, 926 injury, 1 death
Newest reports for this brand
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
3006630150-2026-05422 · Received Jul 30, 2026 · Event dated Jul 1, 2025
Device type: Prosthesis, Spinous Process Spacer/Plate (NQO)
Device problem as coded: Lack of Effect
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
3006630150-2026-05421 · Received Jul 30, 2026 · Event dated Jul 1, 2025
Device type: Prosthesis, Spinous Process Spacer/Plate (NQO)
Device problem as coded: Lack of Effect
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
3006630150-2026-01128 · Received Feb 26, 2026 · Event dated Jan 28, 2026
Device type: Prosthesis, Spinous Process Spacer/Plate (NQO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Boston Scientific Neuromodulation Corporation
Z-2485-2025 · Started Jun 6, 2025 · Posted by FDA Sep 2, 2025
Reason given: As a result of a comprehensive product performance review it was determine that the device and instruments are not consistently meeting expected performance levels. Issues include breakage of the instruments and implant/device.
Cause as FDA categorized it: Device Design · Device type: Prosthesis, Spinous Process Spacer/Plate (NQO)
Boston Scientific Neuromodulation Corporation
Z-1972-2023 · Started May 12, 2023 · Posted by FDA Jun 15, 2023
Reason given: Pending update to indirect decompression system instructions for use informing users that excessive force during the implant procedure may cause driver instrument tip breaks, which may result in metal fragments (Driver teeth/tips) within the implant location; and if metal fragments are not removed and remain in situ,...
Cause as FDA categorized it: Labeling design · Device type: Prosthesis, Spinous Process Spacer/Plate (NQO)
- Superion Indirect Decompression System (IDS) Model Numbers and Size: 101-9808 - 8mm 01-9812 - 12mm 101-9814 - 14mmOpen, Classified
Boston Scientific Neuromodulation Corporation
Z-0230-2023 · Started Oct 12, 2022 · Posted by FDA Nov 14, 2022
Reason given: Due to Indirect Decompression System devices exhibiting a potential for weld breakage at the spindle cap-to-main body interface. As a result of the separation of the spindle cap from the main body it may prevent proper deployment of the device during implantation.
Cause as FDA categorized it: Process change control · Device type: Prosthesis, Spinous Process Spacer/Plate (NQO)
Published research
The most relevant PubMed records for "Superion Interspinous"[tiab]. The summary above synthesizes these.
- Superion Interspinous Spacer Treatment of Moderate Spinal Stenosis: 4-Year Results.
Nunley PD, Patel VV, Orndorff DG, et al. · World Neurosurg · 2017Multicenter Study, Randomized Controlled Trial
- Editorial on: "Superion® InterSpinous Spacer Treatment of Moderate Spinal Stenosis: 4-year Results".
Caporlingua F · J Spine Surg · 2018Editorial, Comment
- Cost-effectiveness and Safety of Interspinous Process Decompression (Superion).
Cairns K, Deer T, Sayed D, et al. · Pain Med · 2019Research Support, Non-U.S. Gov't, Review
- Superion(®) InterSpinous Spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial.
Patel VV, Nunley PD, Whang PG, et al. · J Pain Res · 2015
- Interspinous spacer implant in patients with lumbar spinal stenosis: preliminary results of a multicenter, randomized, controlled trial.
Miller LE, Block JE · Pain Res Treat · 2012
- Superion interspinous process spacer for intermittent neurogenic claudication secondary to moderate lumbar spinal stenosis: two-year results from a randomized controlled FDA-IDE pivotal trial.
Patel VV, Whang PG, Haley TR, et al. · Spine (Phila Pa 1976) · 2015Multicenter Study, Randomized Controlled Trial
- Minimally invasive treatment of moderate lumbar spinal stenosis with the superion interspinous spacer.
Bini W, Miller LE, Block JE · Open Orthop J · 2011
- Rationale, design and clinical performance of the Superion® Interspinous Spacer: a minimally invasive implant for treatment of lumbar spinal stenosis.
Loguidice V, Bini W, Shabat S, et al. · Expert Rev Med Devices · 2011Review
- Biomechanics and Mechanism of Action of Indirect Lumbar Decompression and the Evolution of a Stand-alone Spinous Process Spacer.
Falowski SM, Sayed D, Deer TR, et al. · Pain Med · 2019Research Support, Non-U.S. Gov't, Review
- Cost-effectiveness of three treatment strategies for lumbar spinal stenosis: Conservative care, laminectomy, and the Superion interspinous spacer.
Parker SL, Anderson LH, Nelson T, et al. · Int J Spine Surg · 2015
- Analysis of complications of minimally invasive approaches for symptomatic lumbar spinal stenosis.
Mekhail N, Costandi S, Botros M, et al. · Reg Anesth Pain Med · 2026Research Support, Non-U.S. Gov't
- A Comprehensive Review of Novel Interventional Techniques for Chronic Pain: Spinal Stenosis and Degenerative Disc Disease-MILD Percutaneous Image Guided Lumbar Decompression, Vertiflex Interspinous Spacer, MinuteMan G3 Interspinous-Interlaminar Fusion.
Kaye AD, Edinoff AN, Temple SN, et al. · Adv Ther · 2021Review
Other devices of this type
Also filed under product code NQO.
- Superion Indirect Decompression SystemBoston Scientific Neuromodulation · PMA 2024
- coflex® Interlaminar TechnologyCompanion Spine France · PMA 2026
- X-Stop Interspinous Spacer SystemMedtronic Sofamor Danek, Inc. · PMA 2012
- coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2021
- X Stop Interspinous Process Decompression SystemMedtronic Sofamor Danek, Inc. · PMA 2006
- DIAM Spinal Stabilization SystemCompanion Spine France Sas · PMA 2025
- Paradigm Spine Coflex Interlaminar Stabilization DeviceCompanion Spine France · PMA 2018
- X-Stop LtosMedtronic Sofamor Danek, Inc. · PMA 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.